Name | JMS-17-2 hydrochloride |
---|
Description | JMS-17-2 hydrochloride is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JMS-17-2 hydrochloride impairs metastatic seeding and colonization of breast cancer cells[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.32 nM (CX3CR1)[1] |
In Vivo | JMS-17-2 (10 mg/kg; aministered i.p.; twice a day for three weeks) causes a dramatic reduction of tumors in both skeleton and visceral organs in SCID mice[1]. Animal Model: SCID mice (~25g) with MDA-231 xenograft[1] Dosage: 10 mg/kg Administration: Aministered i.p.; twice a day for three weeks Result: Caused a dramatic reduction of tumors in both skeleton and visceral organs. |
References |
Molecular Formula | C25H27Cl2N3O |
---|---|
Molecular Weight | 456.41 |